The acylcarnitine profiles obtained from dried blood spots on "Guthrie cards" have been widely used for the diagnosis and follow-up of children suspected of carrying an inherited error of metabolism, but little attention has been paid to potential age-related variations in the reference values. In this study, we evaluated the variations in free carnitine and acylcarnitine concentrations with age, as measured by tandem mass spectrometry. Methods: Filter-paper blood spots were collected from 433 healthy individuals over a period of 17 months. Eight age groups were defined: cord blood, 3-6 days (control group), 15-55 days, 2-18 months, 19 -59 months, 5-10 years, 11-17 years, and 18 -54 years. Free carnitine and acylcarnitines were measured for each individual. Mean values were calculated for each age group and compared with those for the control group. Results: Free carnitine was significantly higher in older children than in newborns (P <0.05), but the concentrations of several acylcarnitines tended to be significantly lower in cord blood and in groups of older children than in the control group. Only minor sex-related differences were observed. Conclusion: Although the risk of underdiagnosis of fatty acid oxidation disorders with the use of newborn values as reference can be considered as small, in some circumstances the use of age-related reference values
From November 2001 to March 2003, whole-blood FC and AC profiles were obtained by MS/MS from dried-bloodspot samples collected on Schleicher & Schuell Grade 903 filter paper from 433 healthy individuals. The study population was divided in age groups corresponding to important changes in growth and feeding patterns (see Table 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem. org/content/vol51/issue4/). Individuals were excluded from the study in case of vegetarian diet, chronic or acute illness, congenital malformation syndromes, or use of medications.
The control group corresponded to the classic neonatal screening group: 117 dried-blood-spot samples received at the Newborn Screening Center on one single, randomly selected day were used to compute mean values for the control group. Premature infants (Ͻ37 weeks), infants with a low birth weight (Ͻ2500 g), and newborns younger than 3 days or older than 6 days were excluded from the control group. The FC and AC values in this group were not significantly different from reference values obtained from a population of 10 000 newborns previously tested in our laboratory during 2002 (our unpublished data).
Group A (cord blood), which should reflect the situation of the fetus, comprised 67 umbilical cord blood samples collected on filter paper. These newborns (Ն36 weeks of gestational age) were considered appropriate for gestational age, and their birth weight ranged from 2500 to 4150 g. Of the 67 infants, 60 had been delivered vaginally. The remaining had been delivered by cesarean section, which was indicated for breech presentation and cephalopelvic disproportion. All mothers had a normal outcome. None of these infants presented with signs of severe hypoxia during delivery. The Apgar scores of these newborns ranged from 6 to 10 at the first minute of life. All newborns also had a favorable outcome, without complications until discharge.
Group B (15-55 days; n ϭ 30) corresponded to the "full lactation" group, i.e., receiving frequent feedings (6 -8 bottles/day) and presenting with rapid growth. Group C (2-18 months; n ϭ 17) corresponded to the period of diversification of diet, reduction in the number of meals (4 -5/day), and lengthening of the overnight fast. Group D (19 -59 months; n ϭ 51) corresponded to preschool age, group E (5-10 years; n ϭ 70) to school age, and group F (11-17 years; n ϭ 32) to adolescence (rapid growth).
For groups B through F, samples were collected simultaneously with routine preoperative blood tests from healthy children who had minor elective surgical procedures, except for 16 children attending an elementary school. For children to be eligible for the study, parents were required to respond to a questionnaire. Of a total of 207 questionnaires, only 200 were analyzed because 7 children were later found to be on medication (antibiotics) or special diets, and/or had a diagnosis of chronic disease.
Group G (18 -54 years; n ϭ 49) corresponded to adulthood. Adult volunteers were recruited among the hospital staff. Each volunteer was also requested to answer a questionnaire. Blood was not collected from volunteers identified as having chronic and/or acute health problems or who were on medications. The questionnaire did not include information about smoking. The mean (SD) body mass index for this group was 21.88 (2.99) kg/m 2 .
ethics approval and consent sample preparation and analytical procedure All samples (whole blood) were collected on Schleicher & Schuell Grade 903 filter paper and analyzed by a previously described electrospray-MS/MS method (9, 10 ) , with slight modifications. This filter paper meets NCCLS and CDC specifications.
The analytical procedure is based on butyl ester derivatives of amino acids and ACs. This is the classic procedure used by many newborn-screening centers. Briefly, single disks are punched from each dried blood spot with a standard 3-mm puncher. The different analytes (FC and AC) are extracted from each sample for 30 min at room temperature in 96-well microplates with 200 L of methanol (Chromasolv grade) containing a mixture of the respective stable-isotope-labeled internal standards (Cambridge Isotopes). For ACs, the internal standards includes deuterated free carnitine (C0), C2, C3, C4, C5, C8, C14, and C16. The solution is then evaporated to dryness on a heating block at 55°C under nitrogen. Butanolic HCl 
ms analyses
For our analyses, we used an API 365 triple quadrupole tandem mass spectrometer (Perkin-Elmer Sciex) with an ion spray source. Samples were introduced through the tandem mass spectrometer by the atmospheric pressure ionization (API) system, in which different analytes and their internal standards were recognized by sorting their respective mass-to-charge ratio (m/z). We calculated the FC and AC concentrations by comparing the ion mass spectra of the different analytes with the spectra of their corresponding internal standards. MS/MS was carried out as described previously in detail (9 -11 ) , with slight modifications.
statistical analysis
For all analytes, means of age groups were calculated by an ANOVA model that included, in addition to age group, the age of the patient. We used the Tukey test procedure to test differences between the control age group mean and all age group means (12 ) . Calculations were performed with the SAS ANOVA procedure (12 ) . Statistical significance was defined as a P value Ͻ0.05.
Results

control group
Reference values computed from 117 dried-blood-spot samples obtained during the study were not different from reference values computed from 10 000 samples obtained on Schleicher & Schuell 903 filter paper and analyzed throughout 2002 (unpublished data). The FC and short-, medium-, and long-chain AC concentrations in groups A through G obtained by MS/MS were compared with those of the control group. The reference intervals and mean AC and FC values in the different groups are shown in Tables 1, 2, and 3. fc and short-chain ACs Althought FC concentrations in groups A and B did not differ significantly from the FC concentration for the control group, mean FC concentrations were significantly higher in groups C through G (Table 1) .
Although the short-chain AC concentrations [C2, malonylcarnitine (C3:DC), C4, hydroxybutyrylcarnitine (C4OH), and glutarylcarnitine (C5:DC)] were considerably lower in group A than in the control group, the differences between group A and the control group were not statistically significant for methylmalonylcarnitine (C4:DC), hydroxyisovalerylcarnitine (C5OH), and (C5). However, the mean C3 values were significantly higher in group A than in the control group.
The C2, C3, C4, and C4OH concentrations were significantly lower in groups B through F compared with the control group. In group B, C4:DC and C5OH were significantly higher than in the control group. The C3:DC, C5:DC, and C5 concentrations were similar between each of the different age groups and the control group. The short-chain AC concentrations in group G were significantly lower than in the control group for C2, C3:DC, C4, C4OH, C4:DC, and C5:DC, whereas C4:DC and C5OH were significantly higher than in the control group.
medium-chain ACs
The medium-chain AC concentrations in group A were significantly lower than in the control group, with the exception of decenoylcarnitine (C10:1). In groups C through G, hexanoylcarnitine (C6), methylglutarylcarnitine (C6:DC), and dodecanoylcarnitine (C12) concentrations were significantly lower than in the control group (Table 2) .
long-chain ACs
In group A, the concentrations of the long-chain ACs C14, tetradecenoylcarnitine (C14:1), C16, hydroxyoctadecanoylcarnitine (C18OH), octadecenoylcarnitine (C18:1), hydroxyoleylcarnitine (C18:1OH), and octadecadienoylcarnitine (C18:2) were significantly lower than in the control group. The tetradecadienoylcarnitine (C14:2), hydroxytetradecanoylcarnitine (C14OH), and hydroxypalmitoylcarnitine (C16OH) concentrations in group A were not significantly different from the control group (Table 3) .
As for medium-chain ACs, the concentrations of the long-chain ACs were lower in groups B through G than in the control group. Although the mean C16OH, C18:1OH, and C18:2 values were significantly lower in group B than in the control group, they were similar for groups C through G. Finally, we found no differences between C14:2 and C14OH concentrations in any of the age groups and the control group.
sex-related differences
Apart from C14, C16, and C18:1 concentrations (results not shown), no other sex-related differences were noted.
Discussion
Measurement of FC and AC concentrations by MS/MS in whole-blood spots has been described by several authors as an efficient and reliable diagnostic method for the detection of several fatty acid oxidation disorders and organic acidurias (1, 4, 13 ) . Age-related reference values for ACs measured by MS/MS are currently not available, although this could be important for the optimal investigation and management of IEM. Of note, reference values have been reported by Millington (14 ) , but in that study the population age ranged from 0.2 to 16 years and the results were not segregated by age. Considering the metabolic and nutritional changes happening from fetal life to adulthood, we decided to investigate any potential changes in FC and AC concentrations through the different ages.
In our study, FC concentrations were significantly Clinical Chemistry 51, No. 4, 2005 higher in older children than in newborns (control group), but we observed no significant differences between FC concentrations in cord blood and in this same control group. On the other hand, the concentrations of several ACs tended to be significantly lower in cord blood and in groups of older children than in the control group. Only minor sex-related differences were observed in this study. The comparison of absolute values found in different studies can be complicated by the fact that, in most studies, FC and AC concentrations were measured in plasma samples rather than whole blood and by methods other than MS/MS (15) (16) (17) (18) (19) . Despite these differences, some of these studies have also shown that plasma FC concentrations were higher in older children than in newborns. In one study, FC concentrations in males were significantly higher than in females (19 ) .
Some interesting comparisons can be made between our results and those of other studies, in which the whole-blood FC values were also measured by MS/MS. Meyburg et al. (11 ) , who assessed FC values in newborns, The lower AC concentrations found in cord blood (compared with the control group) in our study are similar to those reported previously by Meyburg et al. (11 ) . Contrary to the results reported by Takiyama et al. (19 ) , who found similar serum plasma AC concentrations through the different ages (using a different method of assessment), we found significant variation in AC concentrations across the different age groups. Our results are also in agreement with data published by Chace et al. (10 ) , who measured AC by MS/MS in blood spots of 16 newborns and 16 older patients with confirmed mediumchain acyl coenzyme A dehydrogenase (MCAD) deficiency and found significantly higher concentrations of medium-chain ACs in newborns than in older patients. These same authors suggested that these differences might be attributable to either sample degradation (related to storage of samples from older patients with MCAD deficiency) or renal loss. Nevertheless, we observed the same significant differences between newborns and older children, using samples taken from healthy individuals with no delay between sample collection and the analyses.
In clinical practice, it can be speculated that age-related AC reference values could be meaningful in situations in which the diagnostic cutoff of a metabolic disorder is very close to the reference interval. This may well be the case for methylmalonic aciduria, which may occasionally present with only slight increases in short-chain AC concentrations. Other examples are long-chain acyl CoA dehydrogenase and trifunctional protein deficiencies, in which the diagnosis typically is suggested by modest increases in long-chain ACs (14 ) . In our study, concentrations of long-chain ACs were significantly lower in cord blood and in older children than in the control group. This suggests, at least theoretically, that the diagnosis of these conditions could be missed if the concentrations measured in healthy newborns were used as reference values for older children. This is well illustrated by the C16 values, which in most study groups were more than 50% lower than those in the control group. Similarly, AC cord blood concentrations may also be inappropriate for the diagnosis of such fatty acid oxidation disorders. Furthermore, there is a potential risk of undertreatment when older children with metabolic disorders are managed based on newborn reference values. Age-related AC reference values could also be helpful in other circumstances, such as the investigation of siblings (children with MCAD deficiency who are in stable condition). In this situation, the increase in AC concen- trations may be very subtle. Typically, clinical decompensation occurs only when patients are exposed to a metabolic stress (e.g., severe illness, prolonged fasting, and surgery); otherwise, a diagnosis is unlikely to be established (20, 21 ) . In addition, biochemical abnormalities in older children can be hard to diagnose if the patient is in a fed state and healthy. The cutoffs (reference intervals) for the "age of 5 days" used in our laboratory are shown in Tables 1, 2 , and 3. These cutoffs (5th and 95th centiles) are based on our personal experience with 10 000 "day-5" samples previously analyzed at our laboratory (unpublished data). The procedure to measure FC and ACs in this study was exactly the same, but only AC mean (50th centile) concentrations are shown for each age group.
Conversely, in MCAD deficiency, for example, the concentrations in the pathologic state tend to be markedly higher than the reference interval (14 ) . This is also the case of other IEM, such as propionic aciduria, carnitine palmitoyl transferase deficiency II, and isovaleric acidurias, which are also associated with marked increases in the respective ACs (10, 14 ) . Therefore, the statistically significant but small differences in some AC concentrations seen in our study are unlikely to affect the diagnosis of any of these conditions.
It has been demonstrated that FC and AC values are significantly higher in whole blood than in plasma (7, 15, 22 ) because of the significantly higher concentrations of long-chain ACs in the erythrocyte membrane. Plasma AC concentrations would most likely show a pattern of variation similar to the one observed in whole blood samples. This specific question deserves further studies.
In conclusion, few sex-related differences were observed in our study. Nevertheless, the analysis of whole blood samples by MS/MS disclosed significant age-related variations in AC and FC concentrations. The magnitude of these variations, although statistically significant, was generally small. Although these small variations are unlikely to have a significant impact on the diagnosis of most IEM, they could be useful in a few conditions where the biochemical abnormalities are subtle.
